|
ZNF709 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.74970002323016E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.2018000039582E-08 |
| Normal-vs-Stage2 |
6.39849999999331E-05 |
| Normal-vs-Stage3 |
2.62009969276278E-10 |
| Normal-vs-Stage4 |
3.02089464554456E-11 |
| Stage1-vs-Stage2 |
7.827600E-02 |
| Stage1-vs-Stage3 |
4.296200E-02 |
| Stage1-vs-Stage4 |
5.564000E-03 |
| Stage2-vs-Stage3 |
3.282100E-03 |
| Stage2-vs-Stage4 |
4.797100E-04 |
| Stage3-vs-Stage4 |
2.431000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.18029996887259E-09 |
| Normal-vs-AfricanAmerican |
1.979850E-04 |
| Normal-vs-Asian |
3.54319995565788E-09 |
| Caucasian-vs-AfricanAmerican |
5.868200E-01 |
| Caucasian-vs-Asian |
8.730400E-01 |
| AfricanAmerican-vs-Asian |
6.227200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.075199994651E-08 |
| Normal-vs-Female |
1.83409998300021E-09 |
| Male-vs-Female |
3.793400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.382100016187E-09 |
| Normal-vs-Age(41-60Yrs) |
1.20159999728031E-08 |
| Normal-vs-Age(61-80Yrs) |
3.46350004232221E-09 |
| Normal-vs-Age(81-100Yrs) |
4.537900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.863200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.693200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.987200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.618000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.418000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.328800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.47289999985878E-07 |
| Classical-VS-Follicular |
3.316200E-03 |
| Classical-VS-Other |
6.179200E-01 |
| Classical-VS-Normal |
4.74960004659408E-09 |
| Tall-VS-Follicular |
2.12609996275148E-09 |
| Tall-VS-Other |
1.535150E-01 |
| Tall-VS-Normal |
1.71651581837295E-12 |
| Follicular-VS-Other |
9.030800E-01 |
| Follicular-VS-Normal |
2.25319999999085E-05 |
| Other-VS-Normal |
5.926400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.99659999977619E-07 |
| Normal-vs-N1 |
3.35420580199752E-12 |
| N0-vs-N1 |
3.68149999996348E-06 |
|
|
